BIOMAT Database Logo BIOMAT Database Logo

[Studies on heterogeneity of anti-TSH receptor antibodies: relation of blocking type anti-TSH receptor antibody and stimulating type antibody]. 1988

Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D007141 Immunoglobulin Fc Fragments Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fc Fragment,Fc Fragments,Fc Immunoglobulin,Fc Immunoglobulins,Ig Fc Fragments,Immunoglobulin Fc Fragment,Immunoglobulins, Fc,Immunoglobulins, Fc Fragment,Fc Fragment Immunoglobulins,Fc Fragment, Immunoglobulin,Fc Fragments, Ig,Fc Fragments, Immunoglobulin,Fragment Immunoglobulins, Fc,Fragment, Fc,Fragments, Ig Fc,Immunoglobulin, Fc
D011989 Receptors, Thyrotropin Cell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE). Receptors, Thyroid Stimulating Hormone,TSH Receptors,Thyroid Stimulating Hormone Receptors,Thyrotropin Receptors,LATS Receptors,Receptor, LATS Immunoglobulins,Receptors, LATS,Receptors, Long-Acting Thyroid Stimulator,Receptors, TSH,TSH Receptor,Thyroid Stimulating Hormone Receptor,Thyrotropin Receptor,Receptor, TSH,Receptor, Thyrotropin,Receptors, Long Acting Thyroid Stimulator
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D013967 Thyroiditis, Autoimmune Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis. Autoimmune Thyroiditis,Thyroiditis, Lymphocytic,Thyroiditis, Lymphomatous,Autoimmune Thyroiditides,Lymphocytic Thyroiditides,Lymphocytic Thyroiditis,Lymphomatous Thyroiditides,Lymphomatous Thyroiditis,Thyroiditides, Autoimmune,Thyroiditides, Lymphocytic,Thyroiditides, Lymphomatous

Related Publications

Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies.
November 1987, Clinical endocrinology,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
Blocking type TSH receptor antibodies.
April 2013, Auto- immunity highlights,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
[Hypothyroidism due to blocking type anti-TSH receptor antibodies].
January 2000, Ryoikibetsu shokogun shirizu,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
[Anti-acetylcholine receptor antibody (binding type and blocking type antibodies)].
June 2010, Nihon rinsho. Japanese journal of clinical medicine,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies.
October 1995, Endocrine journal,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
[Immunologic tests: Anti-acetylcholine receptor antibody (non-blocking type and blocking type antibodies)].
July 2005, Nihon rinsho. Japanese journal of clinical medicine,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
TSH receptor blocking antibodies.
November 2008, Thyroid : official journal of the American Thyroid Association,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
[Studies on monoclonal antibodies to TSH receptors--heterogeneity and pathophysiological significance of antibodies to TSH receptor].
December 1986, Nihon Naibunpi Gakkai zasshi,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
[Idiopathic myxedema and blocking type antibodies to TSH receptor].
August 1999, Nihon rinsho. Japanese journal of clinical medicine,
Y Watanabe, and T Ishigami, and M Takahashi, and N Amino, and H Tamaki, and Y Iwatani, and K Miyai
Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
April 2003, Clinical endocrinology,
Copied contents to your clipboard!